XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statement of Changes in Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (loss)
Balance at beginning of period (shares) at Dec. 31, 2023   10,440,591      
Balance at beginning of period at Dec. 31, 2023 $ 173,334 $ 104 $ 119,441 $ 71,117 $ (17,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 4,088     4,088  
Other comprehensive (loss) income, net of tax (702)       (702)
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (shares)   (9,471)      
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (113)   (113)    
Restricted common stock awarded under the equity incentive plan (shares)   16,955      
Restricted common stock issued upon achievement of performance criteria (shares)   8,805      
Common stock repurchased (shares)   (50,000)      
Common stock repurchased (598)   (570) (28)  
Stock based compensation expense 158   158    
Cash dividends (3,346)     (3,346)  
Balance at end of period (shares) at Mar. 31, 2024   10,406,880      
Balance at end of period at Mar. 31, 2024 172,821 $ 104 118,916 71,831 (18,030)
Balance at beginning of period (shares) at Dec. 31, 2023   10,440,591      
Balance at beginning of period at Dec. 31, 2023 $ 173,334 $ 104 119,441 71,117 (17,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock options exercised (shares) 2,000        
Balance at end of period (shares) at Dec. 31, 2024   9,981,996      
Balance at end of period at Dec. 31, 2024 $ 179,084 $ 100 114,564 80,840 (16,420)
Balance at beginning of period (shares) at Mar. 31, 2024   10,406,880      
Balance at beginning of period at Mar. 31, 2024 172,821 $ 104 118,916 71,831 (18,030)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,675     3,675  
Other comprehensive (loss) income, net of tax 633       633
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (shares)   (539)      
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (6)   (6)    
Common stock repurchased (shares)   (109,000)      
Common stock repurchased (1,236) $ (1) (1,230) (5)  
Stock based compensation expense 158   158    
Balance at end of period (shares) at Jun. 30, 2024   10,297,341      
Balance at end of period at Jun. 30, 2024 176,045 $ 103 117,838 75,501 (17,397)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,286     3,286  
Other comprehensive (loss) income, net of tax 3,552       3,552
Common stock repurchased (shares)   (223,205)      
Common stock repurchased (2,893) $ (2) (2,542) (349)  
Stock based compensation expense 159   159    
Balance at end of period (shares) at Sep. 30, 2024   10,074,136      
Balance at end of period at Sep. 30, 2024 180,149 $ 101 115,455 78,438 (13,845)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 2,702     2,702  
Other comprehensive (loss) income, net of tax (2,575)       (2,575)
Forfeiture of unvested shares (shares)   (246)      
Common stock options exercised (shares)   2,000      
Common stock options exercised 22   22    
Common stock repurchased (shares)   (93,894)      
Common stock repurchased (1,370) $ (1) (1,069) (300)  
Stock based compensation expense 156   156    
Balance at end of period (shares) at Dec. 31, 2024   9,981,996      
Balance at end of period at Dec. 31, 2024 179,084 $ 100 114,564 80,840 (16,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,197     3,197  
Other comprehensive (loss) income, net of tax 1,455       1,455
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (shares)   (11,481)      
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting $ (183)   (183)    
Restricted common stock issued upon achievement of performance criteria (shares)   16,021      
Common stock options exercised (shares) 3,000 3,000      
Common stock options exercised $ 28   28    
Stock based compensation expense 68   68    
Cash dividends (3,598)     (3,598)  
Balance at end of period (shares) at Mar. 31, 2025   9,989,536      
Balance at end of period at Mar. 31, 2025 $ 180,051 $ 100 $ 114,477 $ 80,439 $ (14,965)